Trade PTC Therapeutics Inc - PTCT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.20 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 50.29 |
| Open | 50.33 |
| 1-Year Change | 94.02% |
| Day's Range | 49.9 - 51.01 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 50.59 | 0.26 | 0.52% | 50.33 | 51.05 | 49.90 |
| Feb 20, 2025 | 50.29 | 0.33 | 0.66% | 49.96 | 50.46 | 49.52 |
| Feb 19, 2025 | 50.36 | 0.39 | 0.78% | 49.97 | 50.83 | 49.57 |
| Feb 18, 2025 | 49.35 | -2.42 | -4.67% | 51.77 | 52.67 | 49.20 |
| Feb 14, 2025 | 51.77 | 2.07 | 4.16% | 49.70 | 51.82 | 49.30 |
| Feb 13, 2025 | 49.60 | 0.43 | 0.87% | 49.17 | 49.68 | 47.55 |
| Feb 12, 2025 | 48.84 | 1.41 | 2.97% | 47.43 | 48.89 | 47.20 |
| Feb 11, 2025 | 48.58 | -0.46 | -0.94% | 49.04 | 49.46 | 47.68 |
| Feb 10, 2025 | 49.77 | 0.14 | 0.28% | 49.63 | 49.94 | 48.78 |
| Feb 7, 2025 | 49.41 | 0.33 | 0.67% | 49.08 | 50.47 | 48.96 |
| Feb 6, 2025 | 49.72 | 0.53 | 1.08% | 49.19 | 50.38 | 48.96 |
| Feb 5, 2025 | 49.91 | 0.78 | 1.59% | 49.13 | 50.57 | 49.09 |
| Feb 4, 2025 | 49.33 | -0.65 | -1.30% | 49.98 | 51.02 | 48.56 |
| Feb 3, 2025 | 49.95 | 4.54 | 10.00% | 45.41 | 50.35 | 45.41 |
| Jan 31, 2025 | 45.77 | 0.80 | 1.78% | 44.97 | 47.50 | 44.96 |
| Jan 30, 2025 | 46.09 | 1.02 | 2.26% | 45.07 | 46.27 | 45.02 |
| Jan 29, 2025 | 45.17 | 0.22 | 0.49% | 44.95 | 46.16 | 44.72 |
| Jan 28, 2025 | 45.14 | -0.95 | -2.06% | 46.09 | 46.09 | 44.99 |
| Jan 27, 2025 | 46.01 | 1.01 | 2.24% | 45.00 | 47.17 | 45.00 |
| Jan 24, 2025 | 46.37 | 1.67 | 3.74% | 44.70 | 46.96 | 44.70 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
PTC Therapeutics Company profile
About PTC Therapeutics, Inc.
PTC Therapeutics, Inc. is a science-driven global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company's portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The Company has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD). It has a pipeline of gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS), including PTC-AADC for the treatment of Aromatic L-Amino Acid Decarboxylase (AADC).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, PTC Therapeutics, Inc. revenues increased 41% to $538.6M. Net loss increased 20% to $523.9M. Revenues reflect United States segment increase of 59% to $297M, Non-US segment increase of 24% to $241.6M. Higher net loss reflects Non-GAAP research and development increase of 11% to $487.1M (expense), Interest expense, net - Balancing value increase of 52% to $85.1M (expense).
Equity composition
Common Stock $0.001 Par, Shares auth 125M., 22,206,190 shares issd,. Insiders Owns approx.68.93%
| Industry: | Bio Therapeutic Drugs |
100 Corporate Ct
SOUTH PLAINFIELD
NEW JERSEY 07080-2400
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com